Abstract
Antibiotics save millions of lives every year. However, some bacteria have become resistant or even multi-resistant to these drugs, and there are already infections that are impossible to treat with the current therapeutic arsenal. Against this backdrop of a very serious threat to health, in 2017 the World Health Organization (WHO) published a list of bacteria classified according to the urgency with which new solutions must be found to eradicate them. To avoid falling into a " post-antibiotic era " where common infections become deadly again, it is therefore urgent to identify new drugs acting on new targets. Among the enzymes that need to be explored to combat microorganisms are those that are unstable and difficult to isolate, including certain metalloenzymes that could not previously be discovered due to a lack of knowledge and technology to characterize them.
GcpE (also known as " IspG ") and LytB (or " IspH ") are oxygen-sensitive enzymes essential to the survival of most bacteria, such as Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii (responsible for nosocomial diseases) and Mycobacterium tuberculosis (agent of tuberculosis). These two enzymes, absent in humans, catalyze the last two steps of the methylerythritol phosphate pathway, producing isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), the precursors essential for terpenoid synthesis. GcpE and LytB catalyze unconventional reactions using a [4Fe-4S]2+ center involved in two-electron transfer and water elimination. These reactions involving bioinorganic or even bioinorganometallic intermediates are a source of inspiration for the development of new antibacterial strategies. This seminar covered the discovery, characterization and breakthroughs achieved in elucidating the catalytic mechanism of these enzymes, as well as the exploitation of the initial results to design new, highly effective inhibitors.
References
[1] World Health Organization, " Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis ", 2017.
[2] Ahrens-Botzong A., Janthawornpong K., Wolny J.A., Ngouamegne Tambou E., Rohmer M., Krasutsky S., Poulter C.D., Schünemann V. and Seemann M., " Biosynthesis of isoprene units: mössbauer spectroscopy of substrate and inhibitor binding to the [4Fe-4S] cluster of the LytB/IspH enzyme ," Angewandte Chemie International Edition, vol. 50,no. 50, 2011, pp. 11976-11979, https://doi.org/10.1002/anie.201104562.
[3] Janthawornpong K., Krasutsky S., Chaignon P., Rohmer M., Poulter C.D. and Seemann M., " Inhibition of IspH, a [4Fe-4S]2+ enzyme involved in the biosynthesis of isoprenoids via the methylerythritol phosphate pathway ", Journal of the American Chemical Society, vol. 135, 2013, pp. 1816-1822, https://doi.org/10.1021/ja309557s.
[4] Wang W. and Oldfield E., " Bioorganometallic chemistry with IspG and IspH: Structure, function, and inhibition of the [Fe4S4] proteins involved in isoprenoid biosynthesis ," Angewandte Chemie International Edition, vol. 53,no. 17, 2014, pp. 4294-4310, https://doi.org/10.1002/anie.201306712.
[5] Faus I., Reinhard A., Rackwitz S., Wolny J.A., Schlage K., Wille H.C., Chumakov A., Krasutsky S., Chaignon P., Poulter C.D., Seemann M. and Schünemann V., " Isoprenoid biosynthesis in pathogenic bacteria: Nuclear resonance vibrational spectroscopy provides insight into the unusual [4Fe-4S] cluster of the E. coli LytB/IspH protein ," Angewandte Chemie International Edition, vol. 54,no. 43, 2015, pp. 12584-12587, https://doi.org/10.1002/ange.201502494.
[6] Borel F., Barbier E., Krasutsky S., Janthawornpong K., Chaignon P., Poulter C.D., Ferrer J.-L. and Seemann M., " Further insight into crystal structures of Escherichia coli IspH/LytB in complex with two potent inhibitors of the MEP pathway: A starting point for rational design of new antimicrobials ", ChemBioChem, vol. 18, 2017, pp. 2137-2144, https://doi.org/10.1002/cbic.201700363.
[7] Chaignon P., Petit B.E., Vincent B., Allouche L. and Seemann M., " Methylerythritol phosphate pathway: Enzymatic evidence for a rotation in the LytB/IspH-catalyzed reaction ", Chemistry A European Journal, vol. 26,no. 5, 2020, http://dx.doi.org/10.1002/chem.201904676.
